The U.S. will reportedly approve booster shots for all 3 COVID-19 vaccines at 6 months, not 8


U.S. officials said last week that adults vaccinated with the Pfizer and Moderna COVID-19 vaccines should start getting booster shots eight months after their second dose was administered, starting in mid-September. Now, a person familiar with the plans tells The Wall Street Journal, federal regulators will likely approve boosters for all three approved vaccines — Pfizer, Moderna, and Johnson & Johnson — starting six months after inoculation.
Data the Food and Drug Administration is reviewing from vaccine makers and other countries is based on boosters given at six months, the Journal reports. "The Biden administration and companies have said that there should be enough supply for boosters that they plan to begin distributing more widely on Sept. 20. The U.S. has purchased a combined 1 billion doses from Pfizer and Moderna."
The booster rollout for adults who aren't immunocompromised hinges on FDA approval and a recommendation from a key Centers for Disease Control and Prevention outside vaccine advisory committee. Preliminary studies show significant boosts to immune protections, but "that doesn't mean every patient needs to get a booster at six months," says Leana Wen, health policy professor at George Washington University.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There is some evidence that the vaccines lose some potency after several months and the Delta variant of the coronavirus has infected more vaccinated people than previous strains, although most breakthrough infections are mild.
The discussions about booster shots comes as the U.S. has more than 100,000 COVID-19 patients hospitalized, a level last seen on Jan. 30, before the vaccines were widely available, The Washington Post reports. Nearly a third of those hospitalizations are in Florida (17,000) and Texas (14,000), states with lower-than-average vaccination rates, large populations, and governors opposed to vaccine and mask requirements. The number of new daily cases is also almost back up to January levels — an average of 148,000 cases on Wednesday versus 151,000 on Jan. 30 — but COVID-19 deaths, 1,1000 a day, are much lower than the daily average of 3,100 recorded at the January peak.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
Unraveling autism: RFK Jr.'s vow to find a root cause
Feature RFK Jr. has vowed to find the root cause of the 'autism epidemic' in months. Scientists have doubts.
-
The sneaking rise of whooping cough
Under the Radar The measles outbreak isn't the only one to worry about
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia